Dr. Cather is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9101 N Central Expy
Ste 160
Dallas, TX 75231Phone+1 214-265-1818Fax+1 214-265-1806
Education & Training
University of Texas Health Science Center at HoustonResidency, Dermatology, 1996 - 1999
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1994 - 1995
University of Texas Southwestern Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 2002 - 2026
TX State Medical License 1996 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
- A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Start of enrollment: 2016 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 304 citationsEfficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized c...Carle Paul, J. Cather, Melinda Gooderham, Yves Poulin, Ulrich Mrowietz
The British Journal of Dermatology. 2015-12-01 - 124 citationsLong-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM...Jeffrey J. Crowley, Diamant Thaçi, Pascal Joly, Ketty Peris, Kim A. Papp
Journal of the American Academy of Dermatology. 2017-08-01 - 53 citationsSafety of selective IL-23p19 inhibitors for the treatment of psoriasis.Jeffrey J. Crowley, Richard B. Warren, Jennifer Clay Cather
Journal of the European Academy of Dermatology and Venereology. 2019-06-27
Press Mentions
Mindful Dermatology Shines a Light on Important Skin Conditions Just in Time for SummerApril 20th, 2022- Yes, CBD Creams Relieve Pain. But Science Is Still Learning About the Benefits and RisksJuly 28th, 2020
Select Dermatology Announces Launch of Physician Services Platform Through Partnership with Jennifer Cather, M.D. And Affiliation of Mindful Dermatology, PLLCMay 21st, 2018- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
